SECTOR : Biotech
ENTRY DATE : 2004
EXIT DATE : 2011
BUSINESS : Venture Capital
WEB : www.mutabilis.fr

Mutabilis

Discovery of new therapeutic targets for the development of anti-infectives

Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.